Skip navigation
alt

Signatera Looks Deeper

Ma

Real-world examples of Signatera for immunotherapy monitoring

ON-DEMAND WEBINAR

POSTER PRESENTATION
  • Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer

    Abstract ID: 23
  • Utility of tumor-informed molecular residual disease assays in patients with complete response to immune checkpoint blockade

    Abstract ID: 24
  • Line of therapy adjustment in a patient with advanced triple-negative breast cancer (TNBC) by using personalized ctDNA test for treatment response monitoring

    Abstract ID: 25
  • ctDNA clearance and radiographic resolution of lymph node metastasis in a patient with metastatic microsatellite stable colorectal cancer on immunotherapy

    Abstract ID: 26

Dive Deeper

ctDNA and MRD Testing | Colorectal Cancer Care Tools for Surveillance
Video
Seeing beyond the limit: Detect residual disease and assess treatment response
Whitepaper
A personalized, tumor informed approach to detect molecular residual disease with high sensitivity and specificity
Whitepaper

Learn More

Presentations are available for on-demand viewing and download. Sign up here to receive up-to-date information about Signatera.